Health Equity in Healthy People 2030

We estimate that if the PHE expires in April 2023, 18.0 million people will lose Medicaid coverage in the following…

Charitable Pharmacies of America organization member receives Health Equity grant

In 2011, the opioid crisis reached astounding levels with over 21,000 deaths adding to the urgency of providing aid to those who most need it

How a ‘weighted lottery’ helped underserved patients get a scarce Covid drug

Significant improvement in glycemic control among participants demonstrates the substantial impact that pharmacies partnered with charitable medication distributors such as the Dispensary of Hope can have on individuals with insulin-treated T2D

There are multiple factors that will impact an individual patient’s choice on how to go about getting their prescription medication. It can be overwhelming to navigate this complex issue.

An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.

Uninsured adults and those in worse health continue to report higher rates of not getting care due to costs

Good Pill will provide direct access to hundreds of life-saving medications and save families $150+/month on healthcare cost

The Outcomes of Implementing and Integrating Comprehensive Medication Management in Team-Based Care: A Review of the Evidence on Quality, Access and Costs, December 2023

Want to learn more about Free and Charitable Clinics, Charitable Pharmacies and the medically underserved?

Good Pill will provide direct access to hundreds of life-saving medications and save families $150+/month on healthcare cost

Federal/state grants are not the only gateways to funding. There are close to 750 “community foundations” nationwide which are public charities dedicated to improving the lives of people in a defined local geographic area.

An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.

Recent federal legislative and regulatory updates in managed care pharmacy have prioritized topics ranging from expedited access to novel therapeutics to the health disparities and equity concerns affecting patient populations nationwide, but progress on these developments will depend on the impact of the midterm elections